2026 data FDA MAUDE openFDA FDA Class II

Device, Neurovascular Embolization

Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.

OpenFDA device adverse-event casebook.

FDA Class II (moderate risk, special controls required), regulated under 21 CFR §882.5950 (Neurology panel).

FDA MAUDE casebook

openFDA event book Device, Neurovascular Embolization MID-BOOK · MAUDE

#117 of 1000 · 26,211 reports · 1995–2026

  • BOOK 26,211 reports
  • RANK #117 of 1000
  • DEATH 640 death-typed
  • INJ 6,282 injury-typed
  • MALF 19,139 malfunction
  • SPAN 1995–2026
  • PEAK 2017: 2,494
  • PHOTO Tubes

Nearest event-volume peer: Tubes, Gastrointestinal (And Accessories) (139 report gap)

Device, Neurovascular Embolization sits #117 of 1000 among tracked device types with 26,211 MAUDE reports spanning 1995–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →

Malfunction reports run above the device-type norm

Device, Neurovascular Embolization carries 73.0% MALFUNCTION-coded reports, 8.2pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.

  • DEATH 2.4% corpus 1.5% · above corpus mean (+0.9 pp)
  • INJ 24.0% corpus 30.3% · below corpus mean (-6.3 pp)
  • MALF 73.0% corpus 64.8% · above corpus mean (+8.2 pp)

Lead product-problem code Failure to Advance is 15% of coded problems · Lead manufacturer PENUMBRA, INC. accounts for 61% of manufacturer-tagged reports · Top event location is 49% of location-tagged rows .

Device, Neurovascular Embolization in the event-volume neighbourhood

FDA MAUDE report totals among this device type and nearest nationwide peers

reports

What this shows Device, Neurovascular Embolization carries 26,211 MAUDE reports, ranked #117 of 1000.

Source FDA MAUDE via openFDA, aggregated by PlainHospital As of August 2026

Event Types

Malfunction 19,139 (73.0%)
Injury 6,282 (24.0%)
Death 640 (2.4%)
97 (0.4%)
Other 53 (0.2%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

18,873 (67.1%)
Required Intervention 3,762 (13.4%)
Other 1,396 (5.0%)
R 1,024 (3.6%)
Death 644 (2.3%)
Hospitalization 610 (2.2%)
Life Threatening 465 (1.7%)
Disability 392 (1.4%)
S 346 (1.2%)
O 281 (1.0%)
L 235 (0.8%)
H 91 (0.3%)
D 13 (0.0%)
Congenital Anomaly 4 (0.0%)
C 1 (0.0%)

Top Product Problems

Failure to Advance 4,257
Physical Resistance/Sticking 2,613
Adverse Event Without Identified Device or Use Problem 2,494
Premature Separation 2,463
Detachment Of Device Component 2,119
Physical Resistance 2,080
Stretched 1,939
Break 1,506
Premature Activation 1,481
Positioning Failure 1,226
Separation Failure 987
Kinked 743
Material Deformation 740
Other (for use when an appropriate device code cannot be identified) 701
Detachment of Device or Device Component 677
Migration or Expulsion of Device 611
Fracture 595
Difficult to Remove 534
Unraveled Material 532
Mechanical Problem 531

Yearly Trend

95
1995: 2
96
1996: 3
97
1997: 70
98
1998: 98
99
1999: 67
00
2000: 56
01
2001: 85
02
2002: 253
03
2003: 208
04
2004: 285
05
2005: 336
06
2006: 585
07
2007: 326
08
2008: 730
09
2009: 821
10
2010: 851
11
2011: 894
12
2012: 1,146
13
2013: 1,103
14
2014: 1,729
15
2015: 1,598
16
2016: 1,991
17
2017: 2,494
18
2018: 2,058
19
2019: 1,763
20
2020: 1,754
21
2021: 2,268
22
2022: 663
23
2023: 568
24
2024: 552
25
2025: 545
26
2026: 309

Reports in 2025 (545) held close to the prior two-year average of 560.

Related Entities for Device, Neurovascular Embolization

Event Locations

12,952 (49.4%)
I 12,660 (48.3%)
HOSPITAL 435 (1.7%)
NO INFORMATION 66 (0.3%)
OTHER 39 (0.1%)
INVALID DATA 25 (0.1%)
NOT APPLICABLE 17 (0.1%)
UNKNOWN 13 (0.0%)
HOME 1 (0.0%)
OPERATING ROOM 1 (0.0%)
OUTPATIENT DIAGNOSTIC FACILITY 1 (0.0%)
OUTPATIENT TREATMENT FACILITY 1 (0.0%)

Compare PENUMBRA, INC. vs STRYKER NEUROVASCULAR CORK →

Nationwide devices with a comparable volume-and-death footprint

Two openFDA-derived peer sets for Device, Neurovascular Embolization: nearest by total report volume and nearest by death-typed count, each floored at ≥100 reports so the neighborhoods stay in the advertised mass.

Similar report volume

Nearest other device types by FDA MAUDE report count (26,211 here).

Similar death-typed counts

Nearest other device types by death-typed report count (640 here), distinct from the volume row.

Disclaimer: MAUDE figures for Device, Neurovascular Embolization are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.

Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Device, Neurovascular Embolization; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.